Launched VIZZ™ (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product ...
OSN Cornea/External Disease Board Member Eric D. Donnenfeld, MD, and a panel of experts examined a series of unusual ...
Exclusive distribution agreement includes revenue sharing in addition to upfront and milestone payments to LENZ ...
Stocks like Tata Steel, NCL Industries, Infosys, Gland Pharma, Cipla, IRB Infrastructure Developers, Meesho, Adani Green ...
Okyo Pharma appointed Robert J. Dempsey to serve as the company’s next CEO, according to a press release.
A company claiming to be “America’s Largest Ophthalmic Pharmacy” has issued a recall for multiple eye drop products for the ...
An update from Cloudbreak Pharma, Inc. ( ($HK:2592) ) is now available. Cloudbreak Pharma has announced that its wholly owned U.S. subsidiary, ADS ...
Detailed price information for Hyperion Defi Inc (HYPD-Q) from The Globe and Mail including charting and trades.
Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...
Recently, VivaVision Biotech (VivaVision), a late clinical-stage, privately-held biotech company focused on developing innovative ophthalmic drugs, announced that it has received the written meeting ...
Surrey World on MSN
A cut above the rest: Surrey salon owner transforms her vision
With a strong prescription of -6 which made everyday vision challenging, and a job which requires excellent sight, Jacquie ...
Board Confirms Leadership Team to Execute 2026 Strategic PrioritiesCompany Also Appoints Robert Rubenstein as General CounselLAGUNA HILLS, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback